PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+35.59%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$9.28B
AUM Growth
+$9.28B
Cap. Flow
+$1.17B
Cap. Flow %
12.62%
Top 10 Hldgs %
43.31%
Holding
162
New
36
Increased
23
Reduced
15
Closed
21

Top Buys

1
NVTA
Invitae Corporation
NVTA
$305M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$226M
3
AVIR icon
Atea Pharmaceuticals
AVIR
$130M
4
CCCC icon
C4 Therapeutics
CCCC
$105M
5
KRON
Kronos Bio
KRON
$83M

Top Sells

1
MYOK
MyoKardia, Inc. Common Stock
MYOK
$190M
2
CRSP icon
CRISPR Therapeutics
CRSP
$112M
3
IMMU
Immunomedics Inc
IMMU
$77.6M
4
BPMC
Blueprint Medicines
BPMC
$61.6M
5
KOD icon
Kodiak Sciences
KOD
$42.8M

Sector Composition

1 Healthcare 85.79%
2 Industrials 0.29%
3 Materials 0.22%
4 Financials 0.13%
5 Consumer Discretionary 0.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALBO
26
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$88.5M 0.95%
2,360,139
– –
QTNT
27
DELISTED
Quotient Limited Ordinary Shares
QTNT
$84.4M 0.91%
405,020
– –
KRON
28
DELISTED
Kronos Bio
KRON
$83M 0.89%
+2,780,097
New +$83M
ARWR icon
29
Arrowhead Research
ARWR
$3.84B
$82.2M 0.88%
+1,070,814
New +$82.2M
SLDB icon
30
Solid Biosciences
SLDB
$448M
$81.9M 0.88%
720,257
+270,270
+60% +$30.7M
CHRS icon
31
Coherus Oncology, Inc. Common Stock
CHRS
$146M
$81.2M 0.87%
4,671,836
+1,035,351
+28% +$18M
CERE
32
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$75.3M 0.81%
+4,544,062
New +$75.3M
PRVB
33
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$71.6M 0.77%
4,224,389
-41,322
-1% -$700K
KDMN
34
DELISTED
Kadmon Holdings, Inc.
KDMN
$65.2M 0.7%
15,711,334
– –
IMVT icon
35
Immunovant
IMVT
$2.91B
$64.7M 0.69%
1,400,000
– –
ONCR
36
DELISTED
Oncorus, Inc.
ONCR
$64.3M 0.69%
+1,989,987
New +$64.3M
NARI
37
DELISTED
Inari Medical, Inc. Common Stock
NARI
$58.4M 0.63%
668,500
-180,000
-21% -$15.7M
ZNTL icon
38
Zentalis Pharmaceuticals
ZNTL
$123M
$54.5M 0.59%
1,050,003
– –
PMVP icon
39
PMV Pharmaceuticals
PMVP
$82.1M
$54.5M 0.58%
885,556
+280,000
+46% +$17.2M
TARS icon
40
Tarsus Pharmaceuticals
TARS
$2.44B
$53.6M 0.58%
+1,296,416
New +$53.6M
ADPT icon
41
Adaptive Biotechnologies
ADPT
$1.96B
$53.5M 0.57%
904,854
+74,854
+9% +$4.43M
CRNX icon
42
Crinetics Pharmaceuticals
CRNX
$3.26B
$51.6M 0.55%
3,659,381
– –
UROV
43
DELISTED
Urovant Sciences Ltd.
UROV
$50.3M 0.54%
3,116,831
+750,000
+32% +$12.1M
CMPS
44
Compass Pathways
CMPS
$452M
$49.9M 0.54%
1,047,404
– –
AGRX
45
DELISTED
Agile Therapeutics, Inc
AGRX
$45.7M 0.49%
7,960
– –
ARNA
46
DELISTED
Arena Pharmaceuticals Inc
ARNA
$44.2M 0.47%
575,007
-50,122
-8% -$3.85M
FMTX
47
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$43.6M 0.47%
1,250,000
– –
ALDX icon
48
Aldeyra Therapeutics
ALDX
$350M
$43.1M 0.46%
6,285,458
– –
STOK icon
49
Stoke Therapeutics
STOK
$1.08B
$41.6M 0.45%
671,978
– –
COLL icon
50
Collegium Pharmaceutical
COLL
$1.25B
$41.2M 0.44%
2,058,068
– –
1
2
3 4 5